{"id":23145,"date":"2022-04-04T11:49:04","date_gmt":"2022-04-04T11:49:04","guid":{"rendered":"https:\/\/sbpt.org.br\/portal\/?p=23145"},"modified":"2022-04-04T11:49:04","modified_gmt":"2022-04-04T11:49:04","slug":"consulta-publica-hap-2022","status":"publish","type":"post","link":"https:\/\/sbpt.org.br\/portal\/consulta-publica-hap-2022\/","title":{"rendered":"SBPT aponta equ\u00edvocos na proposta de tratamento da Hipertens\u00e3o Arterial Pulmonar (HAP) da CONITEC"},"content":{"rendered":"<p style=\"text-align: justify\">A CONITEC abriu consulta p\u00fablica a respeito do PCDT de tratamento da Hipertens\u00e3o Arterial Pulmonar (HAP) e disponibilizou para contribui\u00e7\u00f5es at\u00e9 04\/04\/2022.<\/p>\n<p style=\"text-align: justify\">O documento apresentado trata das drogas aprovadas pela ANVISA para tratamento da HAP, em monoterapia ou em terapia combinada.<\/p>\n<p style=\"text-align: justify\">De acordo com os pneumologistas da Comiss\u00e3o Cient\u00edfica de Circula\u00e7\u00e3o Pulmonar da SBPT, a network metan\u00e1lise (NMA) apresentada pela CONITEC apresenta diversos problemas metodol\u00f3gicos que podem comprometer seriamente os resultados encontrados.<\/p>\n<p style=\"text-align: justify\">Por isso, a SBPT apresentou a seguinte resposta \u00e0 consulta p\u00fablica:<\/p>\n<div class=\"wp-block-button aligncenter is-style-default\"><a class=\"wp-block-button__link\" href=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2022\/04\/Resposta-SBPT-Consulta-p\u00fablica-n-6-HAP.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Resposta da SBPT \u00e0 Consulta P\u00fablica n. 6 &#8211; Ambrisentana, bosentana, iloprosta, selexipague e sildenafila para o tratamento de pacientes com hipertens\u00e3o arterial pulmonar<\/a><\/div>\n<p style=\"text-align: justify\">A \u00fanica combina\u00e7\u00e3o de vasodilatadores aceita e proposta pelo documento foi a de sildenafila e bosentana, o que demonstra desconhecimento a respeito da evolu\u00e7\u00e3o das estrat\u00e9gias terap\u00eauticas para essa doen\u00e7a cr\u00f4nica, grave e progressiva.<\/p>\n<p style=\"text-align: justify\">Em todo o mundo, outras associa\u00e7\u00f5es s\u00e3o utilizadas rotineiramente, com benef\u00edcio respaldado em estudos cl\u00ednicos de qualidade. Ap\u00f3s 8 anos de espera por um documento que pudesse garantir um tratamento adequado aos pacientes com HAP, uma vez que o PCDT de 2014 j\u00e1 era obsoleto e equivocado desde a sua publica\u00e7\u00e3o, a nova vers\u00e3o do PCDT nos trouxe grande preocupa\u00e7\u00e3o com o futuro do tratamento dos pacientes com a HAP no Brasil.<\/p>\n<p style=\"text-align: justify\">A SBPT, a Associa\u00e7\u00e3o M\u00e9dica Brasileira (AMB), a Sociedade Brasileira de Cardiologia, a Sociedade Brasileira de Reumatologia e a Associa\u00e7\u00e3o Brasileira de Apoio a Fam\u00edlia com Hipertens\u00e3o Pulmonar e doen\u00e7as correlatas divulgaram <a href=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2022\/04\/Carta-\u00e0s-Sociedades-PCDT-HAP-v2.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">uma carta<\/a>, na qual reiteram o desejo de contribuir com a discuss\u00e3o t\u00e9cnica sobre o tratamento da HAP e refor\u00e7am a sua diverg\u00eancia com os crit\u00e9rios adotados.<\/p>\n<div class=\"wp-block-button aligncenter is-style-default\"><a class=\"wp-block-button__link\" href=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2022\/04\/Carta-\u00e0s-Sociedades-PCDT-HAP-v2.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Clique aqui para ler e divulgar a carta<\/a><\/div>\n<div><\/div>\n<div style=\"text-align: justify\">A Sociedade de Pneumologia e Tisiologia do Estado do Rio de Janeiro (SOPTERJ) tamb\u00e9m divulgou uma nota de rep\u00fadio \u00e0 proposta da Conitec. <a href=\"http:\/\/www.sopterj.com.br\/nota-de-repudio-a-proposta-da-conitec-para-o-tratamento-da-hipertensao-arterial-pulmonar-hap\/\" target=\"_blank\" rel=\"noopener noreferrer\">Leia aqui<\/a>.<\/div>\n","protected":false},"excerpt":{"rendered":"A CONITEC abriu consulta p\u00fablica a respeito do PCDT de tratamento da Hipertens\u00e3o Arterial Pulmonar (HAP) e disponibilizou para contribui\u00e7\u00f5es at\u00e9 04\/04\/2022. O documento apresentado trata das drogas aprovadas pela ANVISA para tratamento da HAP, em monoterapia ou em terapia combinada. De acordo com os pneumologistas da Comiss\u00e3o Cient\u00edfica de Circula\u00e7\u00e3o Pulmonar da SBPT, a [\u2026]","protected":false},"author":3,"featured_media":23208,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"ngg_post_thumbnail":0,"footnotes":""},"categories":[68],"tags":[1095,1096,115,416,418,94,1097,1098],"class_list":["post-23145","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias","tag-ambrisentana","tag-bosentana","tag-conitec","tag-hap","tag-hipertensao-arterial-pulmonar","tag-hipertensao-pulmonar","tag-iloprosta","tag-selexipague"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SBPT aponta equ\u00edvocos na proposta de tratamento da Hipertens\u00e3o Arterial Pulmonar (HAP) da CONITEC - sbpt.org.br<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sbpt.org.br\/portal\/consulta-publica-hap-2022\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SBPT aponta equ\u00edvocos na proposta de tratamento da Hipertens\u00e3o Arterial Pulmonar (HAP) da CONITEC - sbpt.org.br\" \/>\n<meta property=\"og:description\" content=\"A CONITEC abriu consulta p\u00fablica a respeito do PCDT de tratamento da Hipertens\u00e3o Arterial Pulmonar (HAP) e disponibilizou para contribui\u00e7\u00f5es at\u00e9 04\/04\/2022. O documento apresentado trata das drogas aprovadas pela ANVISA para tratamento da HAP, em monoterapia ou em terapia combinada. De acordo com os pneumologistas da Comiss\u00e3o Cient\u00edfica de Circula\u00e7\u00e3o Pulmonar da SBPT, a [\u2026]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sbpt.org.br\/portal\/consulta-publica-hap-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"sbpt.org.br\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pneumosbpt\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-04T11:49:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2022\/04\/consulta_publica_hap.png\" \/>\n\t<meta property=\"og:image:width\" content=\"350\" \/>\n\t<meta property=\"og:image:height\" content=\"255\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Comunica\u00e7\u00e3o SBPT\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@pneumosbpt\" \/>\n<meta name=\"twitter:site\" content=\"@pneumosbpt\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Comunica\u00e7\u00e3o SBPT\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/consulta-publica-hap-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/consulta-publica-hap-2022\\\/\"},\"author\":{\"name\":\"Comunica\u00e7\u00e3o SBPT\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/person\\\/adba7f33cf32721354590c6f0eb852d4\"},\"headline\":\"SBPT aponta equ\u00edvocos na proposta de tratamento da Hipertens\u00e3o Arterial Pulmonar (HAP) da CONITEC\",\"datePublished\":\"2022-04-04T11:49:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/consulta-publica-hap-2022\\\/\"},\"wordCount\":352,\"publisher\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/consulta-publica-hap-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/consulta_publica_hap.png\",\"keywords\":[\"Ambrisentana\",\"bosentana\",\"CONITEC\",\"HAP\",\"hipertensao arterial pulmonar\",\"hipertens\u00e3o pulmonar\",\"iloprosta\",\"selexipague\"],\"articleSection\":[\"Not\u00edcias\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/consulta-publica-hap-2022\\\/\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/consulta-publica-hap-2022\\\/\",\"name\":\"SBPT aponta equ\u00edvocos na proposta de tratamento da Hipertens\u00e3o Arterial Pulmonar (HAP) da CONITEC - sbpt.org.br\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/consulta-publica-hap-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/consulta-publica-hap-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/consulta_publica_hap.png\",\"datePublished\":\"2022-04-04T11:49:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/consulta-publica-hap-2022\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/consulta-publica-hap-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/consulta-publica-hap-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/consulta_publica_hap.png\",\"contentUrl\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/consulta_publica_hap.png\",\"width\":350,\"height\":255},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/consulta-publica-hap-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SBPT aponta equ\u00edvocos na proposta de tratamento da Hipertens\u00e3o Arterial Pulmonar (HAP) da CONITEC\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#website\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/\",\"name\":\"sbpt.org.br\",\"description\":\"Sociedade Brasileira de Pneumologia e Tisiologia\",\"publisher\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#organization\"},\"alternateName\":\"SBPT\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#organization\",\"name\":\"sbpt.org.br\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/logo-sbpt.png\",\"contentUrl\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/logo-sbpt.png\",\"width\":512,\"height\":512,\"caption\":\"sbpt.org.br\"},\"image\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/pneumosbpt\",\"https:\\\/\\\/x.com\\\/pneumosbpt\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/pneumosbpt\\\/\",\"https:\\\/\\\/www.instagram.com\\\/pneumosbpt\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/socbraspneumol\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/person\\\/adba7f33cf32721354590c6f0eb852d4\",\"name\":\"Comunica\u00e7\u00e3o SBPT\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g\",\"caption\":\"Comunica\u00e7\u00e3o SBPT\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SBPT aponta equ\u00edvocos na proposta de tratamento da Hipertens\u00e3o Arterial Pulmonar (HAP) da CONITEC - sbpt.org.br","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sbpt.org.br\/portal\/consulta-publica-hap-2022\/","og_locale":"pt_BR","og_type":"article","og_title":"SBPT aponta equ\u00edvocos na proposta de tratamento da Hipertens\u00e3o Arterial Pulmonar (HAP) da CONITEC - sbpt.org.br","og_description":"A CONITEC abriu consulta p\u00fablica a respeito do PCDT de tratamento da Hipertens\u00e3o Arterial Pulmonar (HAP) e disponibilizou para contribui\u00e7\u00f5es at\u00e9 04\/04\/2022. O documento apresentado trata das drogas aprovadas pela ANVISA para tratamento da HAP, em monoterapia ou em terapia combinada. De acordo com os pneumologistas da Comiss\u00e3o Cient\u00edfica de Circula\u00e7\u00e3o Pulmonar da SBPT, a [\u2026]","og_url":"https:\/\/sbpt.org.br\/portal\/consulta-publica-hap-2022\/","og_site_name":"sbpt.org.br","article_publisher":"https:\/\/www.facebook.com\/pneumosbpt","article_published_time":"2022-04-04T11:49:04+00:00","og_image":[{"width":350,"height":255,"url":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2022\/04\/consulta_publica_hap.png","type":"image\/png"}],"author":"Comunica\u00e7\u00e3o SBPT","twitter_card":"summary_large_image","twitter_creator":"@pneumosbpt","twitter_site":"@pneumosbpt","twitter_misc":{"Escrito por":"Comunica\u00e7\u00e3o SBPT","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/sbpt.org.br\/portal\/consulta-publica-hap-2022\/#article","isPartOf":{"@id":"https:\/\/sbpt.org.br\/portal\/consulta-publica-hap-2022\/"},"author":{"name":"Comunica\u00e7\u00e3o SBPT","@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/person\/adba7f33cf32721354590c6f0eb852d4"},"headline":"SBPT aponta equ\u00edvocos na proposta de tratamento da Hipertens\u00e3o Arterial Pulmonar (HAP) da CONITEC","datePublished":"2022-04-04T11:49:04+00:00","mainEntityOfPage":{"@id":"https:\/\/sbpt.org.br\/portal\/consulta-publica-hap-2022\/"},"wordCount":352,"publisher":{"@id":"https:\/\/sbpt.org.br\/portal\/#organization"},"image":{"@id":"https:\/\/sbpt.org.br\/portal\/consulta-publica-hap-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2022\/04\/consulta_publica_hap.png","keywords":["Ambrisentana","bosentana","CONITEC","HAP","hipertensao arterial pulmonar","hipertens\u00e3o pulmonar","iloprosta","selexipague"],"articleSection":["Not\u00edcias"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/sbpt.org.br\/portal\/consulta-publica-hap-2022\/","url":"https:\/\/sbpt.org.br\/portal\/consulta-publica-hap-2022\/","name":"SBPT aponta equ\u00edvocos na proposta de tratamento da Hipertens\u00e3o Arterial Pulmonar (HAP) da CONITEC - sbpt.org.br","isPartOf":{"@id":"https:\/\/sbpt.org.br\/portal\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sbpt.org.br\/portal\/consulta-publica-hap-2022\/#primaryimage"},"image":{"@id":"https:\/\/sbpt.org.br\/portal\/consulta-publica-hap-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2022\/04\/consulta_publica_hap.png","datePublished":"2022-04-04T11:49:04+00:00","breadcrumb":{"@id":"https:\/\/sbpt.org.br\/portal\/consulta-publica-hap-2022\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sbpt.org.br\/portal\/consulta-publica-hap-2022\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/sbpt.org.br\/portal\/consulta-publica-hap-2022\/#primaryimage","url":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2022\/04\/consulta_publica_hap.png","contentUrl":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2022\/04\/consulta_publica_hap.png","width":350,"height":255},{"@type":"BreadcrumbList","@id":"https:\/\/sbpt.org.br\/portal\/consulta-publica-hap-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/sbpt.org.br\/portal\/"},{"@type":"ListItem","position":2,"name":"SBPT aponta equ\u00edvocos na proposta de tratamento da Hipertens\u00e3o Arterial Pulmonar (HAP) da CONITEC"}]},{"@type":"WebSite","@id":"https:\/\/sbpt.org.br\/portal\/#website","url":"https:\/\/sbpt.org.br\/portal\/","name":"sbpt.org.br","description":"Sociedade Brasileira de Pneumologia e Tisiologia","publisher":{"@id":"https:\/\/sbpt.org.br\/portal\/#organization"},"alternateName":"SBPT","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sbpt.org.br\/portal\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/sbpt.org.br\/portal\/#organization","name":"sbpt.org.br","url":"https:\/\/sbpt.org.br\/portal\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/logo\/image\/","url":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2026\/10\/logo-sbpt.png","contentUrl":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2026\/10\/logo-sbpt.png","width":512,"height":512,"caption":"sbpt.org.br"},"image":{"@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/pneumosbpt","https:\/\/x.com\/pneumosbpt","https:\/\/www.linkedin.com\/company\/pneumosbpt\/","https:\/\/www.instagram.com\/pneumosbpt\/","https:\/\/www.youtube.com\/user\/socbraspneumol"]},{"@type":"Person","@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/person\/adba7f33cf32721354590c6f0eb852d4","name":"Comunica\u00e7\u00e3o SBPT","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g","caption":"Comunica\u00e7\u00e3o SBPT"}}]}},"_links":{"self":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/posts\/23145","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/comments?post=23145"}],"version-history":[{"count":0,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/posts\/23145\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/media\/23208"}],"wp:attachment":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/media?parent=23145"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/categories?post=23145"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/tags?post=23145"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}